Latest Breaking News On - Novartis pharma - Page 27 : comparemela.com

Samsung Biologics Inks US$390 9 mln Manufacturing Deal with Novartis

Samsung Biologics Inks US$390 9 mln Manufacturing Deal with Novartis
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

Cholla namdoSouth koreaSoult ukpyolsiSouth koreanSamsung biologicsKorea samsung groupSamsung biologics coKorea bizwireSamsung groupNovartis pharma

Form 8-K Bausch Health Companies For: Jun 30

Form 8-K Bausch Health Companies For: Jun 30
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomYork stock exchangeIncorporation or organizationLomb corporationNew york stock exchangeNovartis finance corporationExchange commissionToronto stock exchangeSecurities exchangeLomb ireland limited buyerBausch health companies incSecurities exchange actExact nameIts charterPrincipal executive offices

Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active

Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCzech republicJames loughmanNovartis pharmaIan flitcroftLudger wess ines regina buthMark wuttkeDopavision gmbBoehringer ingelheim venture fundCentre for eye research irelandGerman federal ministry of educationAbabax healthEuropean society of ophthalmologyCongress onTechnological university of dublinPrincipal investigator

Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drug

The sub-licensing agreement for Nilotinib capsules, originally developed by Novartis, will be in 44 low and middle-income countries (LMIC), including the seven countries where patents on the product are pending or in force, Aurobindo Pharma said in a regulatory filing.

Andhra pradeshNovarti nilotinibAurobindo pharmaK nithyananda reddyCharles goreEugia pharma specialities ltdMedicines patent poolPharma vice chairmanManaging directork nithyananda reddyEugia pharma specialitiesNovartis pharmaDirector charles gore

Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop drug

Aurobindo Pharma on Friday said its wholly-owned arm, Eugia Pharma Specialities Ltd has entered into a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and market an anti-cancer drug.

Andhra pradeshK nithyananda reddyNovarti nilotinibAurobindo pharmaCharles goreEugia pharma specialities ltdMedicines patent poolPharma vice chairmanManaging directork nithyananda reddyEugia pharma specialitiesNovartis pharmaDirector charles gore